Neogen Corp. (NEOG) Company Profile & Statistics

Neogen Corp.
NEOG
(Nasdaq - US)
Open
15.18
+0.58 (+3.97%)
in:usd•As of: Nov 18, 2024 12:40 UTC -5
Open
14.81
High
15.38
Low
14.76

About Neogen Corp.

CEO

John E. Adent

Headquarters

620 lesher place

lansing, mi 48912, united states

Auditor

BDO USA, P.C.

Employees

997

Share Holders

532

Website

www.neogen.com

Industry

medical specialties

Sector

health technology

Company Overview

Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada.

Neogen Corp. Statistics

Valuation Measures

Market Capitalization ²	3.29B
Enterprise Value	4.06B
Enterprise Value/EBITDA (ttm)	24.24
Price to Earnings Ratio (ttm)	36.50
Price to Book (mrq)	1.01
Price to Sales (ttm)	3.47
Price to Cash (ytd)	14.24

Profitability

Gross Margin (ttm)	49.56%
Operating Margin (ttm)	9.65%
Profit Margin (ttm)	-2.63%
Return on Equity (ttm)	2.80%
Return on Invested Capital (ttm)	-0.58%
Return on Assets (ttm)	1.93%

Income Statement

Revenue (ttm)	912.20M
Revenue Per Share (ttm)	4.21
Gross Profit (ttm)	452.06M
EBITDA (ttm)³	167.52M
Net Income Avi to Common (ttm)	-23.53M
Diluted EPS (ttm)	-0.11

Share Statistics

Beta (5Y Monthly)	1.23
52-Week Change	-6.76%
S&P500 52-Week Change	29.69%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	216.70M
Dividend Yield	0.00%
Float ⁴	214.25M
% Held by Insiders	1.13%
% Held by Institutions	96.73%

Balance Sheet

Total Cash (mrq)	120.48M
Total Cash Per Share (mrq)	0.56
Total Debt (mrq)	891.78M
Total Debt/Equity (mrq)	28.44%
Current Ratio (mrq)	4.41%
Quick Ratio (mrq)	2.79%
Book Value Per Share (mrq)	14.47

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.08
Free Cash Flow (ytd)	-51.90M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Neogen Corp.

Trade With A Regulated Broker